Paul A. Gardner, MD

Associate Professor of Neurological Surgery
Executive Vice Chairman, Surgical Services
Co-Director, Center for Skull Base Surgery

Paul Gardner




Paul A. Gardner, MD, joined the faculty at the University of Pittsburgh Department of Neurological Surgery in 2008 after completing his residency and fellowship training at the University of Pittsburgh. He completed his undergraduate studies at Florida State University, majoring in biochemistry, and received his medical degree from the University of Pittsburgh School of Medicine.

Dr. Gardner completed a two-year fellowship in endoscopic endonasal pituitary and endoscopic and open skull base surgery. His research has focused on evaluating patient outcomes following these surgeries and more recently on genomic analysis of rare tumors. In April of 2008, Dr. Gardner was named neurosurgical director of the Center for Minimally Invasive Cranial Base Surgery at the University of Pittsburgh Medical Center.

Dr. Gardner's publications can be reviewed through the National Library of Medicine's publication database.

Specialized Areas of Interest

Endoscopic endonasal and open skull base surgery; pituitary tumors; vascular surgery;
cranial nerve disorders; minimally invasive surgery; peripheral nerve surgery.

Hospital Privileges

Children’s Hospital of Pittsburgh of UPMC
UPMC Mercy
UPMC Presbyterian
Veterans Affairs Pittsburgh Healthcare System

Professional Organization Membership

American Association of Neurological Surgeons
American Medical Association
Congress of Neurological Surgeons
North American Skull Base Society
Pennsylvania Neurological Society
Pituitary Network Association

Media Appearances

Pioneering Surgery Saves 5-Year-Old's Life
December 16, 2009
KDKA-TV Evening News

Rare surgery to restore Jain Acharya's eyesight
March 6, 2009

A million well-wishers, 15 doctors point guru to Pittsburgh
February 12, 2009
Pittsburgh Tribune-Review

Research Activities

In addition to continued clinical series examining outcomes following skull base surgery, significant progress has been made with chordoma genomic sequencing. In a project comparing exomes in tumor with patient blood and the known human genome, multiple potential targets for both oncogenesis and possible future treatments have been identified. These targets are currently being evaluated for current knowledge about their involvement in other tumors.

In addition, an ongoing prospective, randomized trial evaluating the role of lumbar drainage following endoscopic endonasal skull base surgery is nearing completion of enrollment.